Bayer | BAYN - Sales Revenues


Bayer reported EUR11.44B in Sales Revenues for its fiscal quarter ending in December of 2025.





Sales Change Date
Air Liquide EUR 6.79B 6.43B Mar/2026
Akzo Nobel EUR 2.39B 20M Mar/2026
Alcon AG USD 2.7B 110M Dec/2025
Amarin USD 49.22M 451K Dec/2025
Arkema EUR 2.11B 80M Dec/2025
AstraZeneca USD 15.29B 213M Mar/2026
BASF EUR 16.02B 1.99B Mar/2026
Bayer EUR 11.44B 1.78B Dec/2025
Beiersdorf EUR 2.48B 170M Mar/2026
Corteva USD 3.91B 1.29B Dec/2025
Covestro EUR 2.92B 255M Dec/2025
Essilor EUR 14.47B 7.6B Dec/2025
Fresenius EUR 5.88B 400M Dec/2025
Fresenius Medical Care EUR 5.07B 180M Dec/2025
Genmab DKK 1.06B 36M Dec/2025
Givaudan CHF 3.61B 256M Dec/2025
GlaxoSmithKline GBP 7.63B 991M Mar/2026
GRIFOLS EUR 1.98B 110M Dec/2025
Henkel EUR 10.09B 4.93B Dec/2025
Hikma Pharmaceutical USD 1.69B 863M Dec/2025
Johnson Matthey GBP 1.28B 4.76B Sep/2025
Linde USD 8.76B 149M Dec/2025
Lonza CHF 3.58B 63M Jun/2025
Merck EUR 5.25B 70M Dec/2025
Novartis USD 13.11B 226M Mar/2026
Nutrien USD 7.03B 1.07B Dec/2025
Philips EUR 5.1B 797M Dec/2025
PPG Industries USD 3.86B 50M Mar/2026
Roche Holding CHF 15.65B 274.5M Dec/2025
Sanofi EUR 11.24B 60M Mar/2026
SAP EUR 9.56B 120M Mar/2026
Solvay EUR 995M 45M Dec/2025
UCB EUR 4.25B 764M Dec/2025
Umicore EUR 10.68B 8.89B Dec/2025
Vinci EUR 16.28B 3.12B Dec/2025